Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $30.65M by Medicaid between Jan 2018 and Dec 2024, across 462 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
FONTANA, CA 92335
FONTANA, CA 92335
33aNPI1689606196assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$30.65M
24GClaims3,049,037
24DCodes billed462
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#7 of 151
Median peer was paid$59K
This provider vs. median519×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 364,316 | $1.06M | |
| 2019 | 441,391 | $940K | |
| 2020 | 310,558 | $844K | |
| 2021 | 380,224 | $2.15M | |
| 2022 | 422,648 | $1.41M | |
| 2023 | 496,699 | $1.59M | |
| 2024incomplete | 633,201 | $22.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 239,363 | 233,629 | $5.48M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 113,599 | 112,432 | $5.14M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.0% | 277,720 | 268,795 | $1.53M |
| 91320 | 4.4% | 11,047 | 11,035 | $1.33M | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.1% | 24,182 | 20,117 | $654K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.1% | 27,586 | 27,304 | $647K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 11,542 | 11,440 | $643K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.9% | 8,314 | 6,467 | $582K |
| 90480 | 1.7% | 13,013 | 12,992 | $522K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 249,369 | 248,454 | $512K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 75,803 | 73,258 | $483K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.4% | 4,334 | 3,761 | $443K |
450 more codes
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.4% | 33,813 | $429K |
| 77386 | 1.3% | 1,016 | $399K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.2% | 4,722 | $379K |
| 0001A | 1.2% | 10,040 | $374K | |
| 0002A | 1.2% | 9,714 | $363K | |
| 90662 | 1.1% | 6,350 | $325K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 8,796 | $315K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 75,892 | $311K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 30,731 | $306K |
| 92015 | Determination of refractive state | <1% | 93,306 | $251K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 11,674 | $229K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 154 | $222K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,373 | $209K |
| 90837 | Psychotherapy session, about an hour | <1% | 9,970 | $205K |
| 92002 | <1% | 22,249 | $199K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 26,913 | $196K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 21,570 | $194K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 6,104 | $183K |
| 71045 | Radiologic examination, chest; single view | <1% | 60,368 | $180K |
| 77080 | <1% | 14,540 | $169K | |
| 0012A | <1% | 4,348 | $166K | |
| 92523 | <1% | 6,544 | $158K | |
| 0011A | <1% | 4,396 | $157K | |
| 73562 | <1% | 23,576 | $155K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 29,545 | $139K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 4,958 | $139K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 5,290 | $136K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 17,001 | $132K |
| 95800 | <1% | 1,039 | $124K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 6,226 | $118K |
| 76641 | <1% | 10,392 | $118K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,931 | $117K |
| 0064A | <1% | 4,251 | $114K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 11,336 | $113K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14,338 | $109K |
| 76830 | Ultrasound, transvaginal | <1% | 14,734 | $109K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15,869 | $105K |
| 73630 | <1% | 32,303 | $104K | |
| 97161 | <1% | 3,505 | $103K | |
| 90677 | <1% | 3,226 | $101K | |
| 99441 | <1% | 21,095 | $98K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 8,556 | $91K |
| 99442 | <1% | 5,826 | $89K | |
| 73030 | <1% | 14,569 | $88K | |
| 11721 | <1% | 4,593 | $87K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 1,420 | $84K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 29,208 | $82K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,476 | $81K |
| J7999 | Compounded drug, not otherwise classified | <1% | 3,169 | $81K |
| 77066 | Tomosynthesis, mammo | <1% | 3,288 | $80K |
| 92551 | <1% | 64,909 | $78K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 8,841 | $77K |
| 73130 | <1% | 18,700 | $74K | |
| 76770 | <1% | 4,163 | $74K | |
| 0071A | <1% | 2,118 | $73K | |
| 73610 | <1% | 23,689 | $72K | |
| 92557 | <1% | 5,159 | $71K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 9,759 | $70K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 20,280 | $68K |
| 77065 | Tomosynthesis, mammo | <1% | 2,270 | $68K |
| 72100 | <1% | 8,622 | $68K | |
| 99443 | <1% | 1,730 | $66K | |
| 73502 | <1% | 5,040 | $66K | |
| 0124A | <1% | 3,380 | $65K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 8,974 | $62K |
| 0072A | <1% | 1,725 | $62K | |
| 90734 | <1% | 4,662 | $62K | |
| 90656 | <1% | 11,032 | $62K | |
| 93971 | <1% | 929 | $62K | |
| 0004A | <1% | 1,773 | $61K | |
| 76536 | <1% | 1,969 | $57K | |
| 76801 | <1% | 3,412 | $54K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 530 | $53K |
| 11055 | <1% | 1,331 | $51K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 55,299 | $51K |
| 73110 | <1% | 14,177 | $50K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 650 | $47K |
| 90686 | <1% | 101,460 | $46K | |
| 0054A | <1% | 2,135 | $46K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 173 | $44K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,940 | $42K |
| 74018 | <1% | 15,494 | $41K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 5,242 | $41K |
| 0134A | <1% | 2,163 | $40K | |
| 81229 | <1% | 383 | $39K | |
| 73564 | <1% | 5,516 | $39K | |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | <1% | 186 | $38K |
| 90651 | <1% | 7,562 | $37K | |
| 52000 | <1% | 76 | $37K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 169 | $37K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,956 | $36K |
| 92567 | <1% | 8,376 | $33K | |
| 93970 | <1% | 277 | $32K | |
| 73140 | <1% | 9,447 | $29K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 698 | $27K |
| 76706 | <1% | 164 | $27K | |
| 95806 | <1% | 441 | $27K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,459 | $26K |
| 72050 | <1% | 2,488 | $26K | |
| 62322 | <1% | 215 | $26K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 734 | $25K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 811 | $24K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 465 | $23K |
| 73100 | <1% | 5,699 | $23K | |
| 81329 | <1% | 1,720 | $23K | |
| 90710 | <1% | 2,064 | $23K | |
| 73523 | <1% | 489 | $22K | |
| 73080 | <1% | 6,235 | $22K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 214 | $22K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 19,595 | $22K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 280 | $20K |
| 73590 | <1% | 6,116 | $19K | |
| 83880 | <1% | 1,698 | $19K | |
| 90679 | <1% | 124 | $19K | |
| 99221 | <1% | 756 | $18K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 109,033 | $17K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,046 | $17K |
| 72040 | <1% | 1,795 | $17K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 698 | $17K |
| 80051 | <1% | 14,409 | $16K | |
| 95782 | <1% | 31 | $16K | |
| 99173 | <1% | 39,249 | $16K | |
| 74183 | <1% | 133 | $16K | |
| 0031A | <1% | 440 | $16K | |
| 82565 | <1% | 16,802 | $15K | |
| 90723 | <1% | 7,763 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,996 | $14K |
| 92134 | <1% | 1,215 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,123 | $14K |
| 83921 | <1% | 1,050 | $13K | |
| 0052A | <1% | 404 | $13K | |
| 76870 | <1% | 811 | $13K | |
| 73090 | <1% | 6,081 | $13K | |
| 71101 | <1% | 1,844 | $13K | |
| 43235 | <1% | 90 | $13K | |
| 82247 | <1% | 11,981 | $13K | |
| 90839 | <1% | 505 | $13K | |
| 72081 | <1% | 4,173 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 37,390 | $12K |
| 73560 | <1% | 1,834 | $12K | |
| 99223 | Prolong inpt eval add15 m | <1% | 352 | $12K |
| 73552 | <1% | 466 | $12K | |
| 90715 | <1% | 3,054 | $12K | |
| 84460 | <1% | 11,415 | $12K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 186 | $11K |
| 73522 | <1% | 313 | $11K | |
| 96417 | <1% | 104 | $11K | |
| 90648 | <1% | 14,311 | $11K | |
| 84075 | <1% | 9,559 | $11K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 128 | $10K |
| 90750 | <1% | 2,920 | $10K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,130 | $10K |
| 93296 | <1% | 165 | $10K | |
| 72082 | <1% | 520 | $10K | |
| 0051A | <1% | 304 | $10K | |
| 72110 | <1% | 367 | $10K | |
| 73060 | <1% | 1,426 | $10K | |
| 74022 | <1% | 1,410 | $9K | |
| 0154A | <1% | 259 | $9K | |
| 72070 | <1% | 1,542 | $8K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 1,070 | $8K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 927 | $8K |
| 72080 | <1% | 851 | $8K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 316 | $8K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 292 | $8K |
| 90670 | <1% | 11,190 | $8K | |
| 88304 | <1% | 2,200 | $7K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 13 | $7K |
| 84450 | <1% | 5,088 | $7K | |
| 72170 | <1% | 780 | $7K | |
| 86360 | <1% | 615 | $7K | |
| 92133 | <1% | 315 | $7K | |
| 73660 | <1% | 1,970 | $7K | |
| 94060 | <1% | 267 | $7K | |
| 81002 | <1% | 15,142 | $7K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 376 | $6K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,002 | $6K |
| 96415 | <1% | 153 | $6K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 852 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 161 | $6K |
| 76881 | <1% | 720 | $6K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 320 | $6K |
| 86359 | <1% | 615 | $6K | |
| 90633 | <1% | 7,367 | $6K | |
| 96156 | <1% | 249 | $6K | |
| 90681 | <1% | 1,141 | $6K | |
| 77073 | <1% | 1,015 | $6K | |
| 74019 | <1% | 358 | $6K | |
| 84484 | <1% | 2,679 | $6K | |
| 82947 | <1% | 9,976 | $5K | |
| 99460 | <1% | 2,720 | $5K | |
| 73070 | <1% | 1,671 | $5K | |
| 00142 | <1% | 40 | $5K | |
| 72220 | <1% | 652 | $5K | |
| 85610 | <1% | 7,259 | $5K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 540 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,639 | $5K |
| 84520 | <1% | 8,167 | $5K | |
| 82105 | <1% | 1,750 | $5K | |
| 90674 | <1% | 7,474 | $5K | |
| 85027 | <1% | 8,705 | $5K | |
| 92504 | <1% | 420 | $4K | |
| 90746 | <1% | 108 | $4K | |
| 77412 | <1% | 89 | $4K | |
| 84702 | <1% | 4,878 | $4K | |
| 77072 | <1% | 1,622 | $4K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 151 | $4K |
| 83690 | <1% | 4,409 | $4K | |
| 92250 | <1% | 2,112 | $4K | |
| 81003 | <1% | 10,630 | $4K | |
| 97165 | <1% | 117 | $4K | |
| 0074A | <1% | 142 | $4K | |
| 73221 | <1% | 155 | $4K | |
| 20610 | <1% | 143 | $4K | |
| 91319 | <1% | 92 | $4K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 65 | $3K |
| 90660 | <1% | 685 | $3K | |
| 20553 | <1% | 308 | $3K | |
| 73565 | <1% | 155 | $3K | |
| 88307 | <1% | 313 | $3K | |
| 77387 | <1% | 130 | $3K | |
| 73000 | <1% | 937 | $3K | |
| 82310 | <1% | 2,059 | $3K | |
| 20552 | <1% | 105 | $3K | |
| 0013A | <1% | 86 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 757 | $3K |
| 82248 | <1% | 1,223 | $3K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 58 | $2K |
| 90707 | <1% | 1,156 | $2K | |
| 0082A | <1% | 75 | $2K | |
| 11056 | <1% | 12 | $2K | |
| 82040 | <1% | 1,682 | $2K | |
| 57160 | <1% | 12 | $2K | |
| 0003A | <1% | 57 | $2K | |
| 81206 | <1% | 38 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 81 | $2K |
| 0081A | <1% | 58 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 28 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 2,034 | $2K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 799 | $2K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 370 | $2K |
| 85379 | <1% | 1,289 | $2K | |
| 90694 | <1% | 110 | $2K | |
| 81243 | <1% | 330 | $2K | |
| 84155 | <1% | 894 | $2K | |
| 90655 | <1% | 648 | $2K | |
| 90716 | <1% | 1,084 | $2K | |
| 86580 | <1% | 1,617 | $2K | |
| 90696 | <1% | 1,756 | $2K | |
| 90700 | <1% | 1,522 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,473 | $1K |
| 93294 | <1% | 14 | $1K | |
| 97162 | <1% | 27 | $1K | |
| 77002 | <1% | 103 | $1K | |
| 83835 | <1% | 79 | $1K | |
| 99205 | Prolong outpt/office vis | <1% | 53 | $1K |
| 97166 | <1% | 25 | $1K | |
| 73650 | <1% | 281 | $1K | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 38 | $1K |
| 92550 | <1% | 103 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 787 | $1K |
| 72120 | <1% | 41 | $1K | |
| 59025 | Fetal non-stress test | <1% | 1,066 | $1K |
| 99417 | Prolong home eval add 15m | <1% | 69 | $1K |
| 31575 | <1% | 12 | $987.37 | |
| 92579 | <1% | 170 | $965.43 | |
| 0053A | <1% | 36 | $960.00 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 25 | $916.97 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 749 | $852.00 |
| 99177 | <1% | 12,626 | $845.96 | |
| 77336 | <1% | 86 | $826.90 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 122 | $826.00 |
| 85730 | <1% | 507 | $720.00 | |
| 98968 | <1% | 439 | $719.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,727 | $716.97 |
| 83605 | <1% | 435 | $706.57 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,720 | $695.44 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 426 | $695.26 |
| 93990 | <1% | 12 | $688.50 | |
| 0112A | <1% | 19 | $680.00 | |
| 36000 | <1% | 30 | $660.00 | |
| 90381 | <1% | 22 | $653.00 | |
| 88342 | <1% | 15 | $630.00 | |
| 99201 | <1% | 1,183 | $624.45 | |
| 71100 | <1% | 27 | $612.48 | |
| 99051 | <1% | 105,194 | $572.37 | |
| 73620 | <1% | 70 | $566.11 | |
| 98967 | <1% | 61 | $564.55 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 178 | $558.00 |
| 92587 | <1% | 606 | $554.00 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 264 | $552.88 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 167 | $538.40 |
| 0111A | <1% | 15 | $520.00 | |
| 81025 | <1% | 1,144 | $496.29 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 609 | $484.86 |
| 70160 | <1% | 93 | $470.00 | |
| 99188 | <1% | 293 | $440.00 | |
| 87210 | <1% | 1,885 | $420.94 | |
| 81015 | <1% | 302 | $407.47 | |
| 85652 | <1% | 1,839 | $404.48 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,226 | $395.70 |
| 93880 | <1% | 26 | $350.20 | |
| 12001 | <1% | 15 | $349.56 | |
| 82950 | <1% | 998 | $343.32 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,276 | $340.09 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 634 | $329.48 |
| 82550 | <1% | 170 | $291.38 | |
| 83615 | <1% | 138 | $255.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 491 | $252.84 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 92 | $247.84 |
| 73120 | <1% | 221 | $239.20 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 18 | $225.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 365 | $210.86 |
| 70360 | <1% | 43 | $199.35 | |
| 84100 | <1% | 297 | $170.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 678 | $161.63 |
| 90672 | <1% | 1,063 | $149.41 | |
| 82962 | <1% | 263 | $140.00 | |
| 96112 | <1% | 112 | $134.00 | |
| 96113 | <1% | 112 | $132.00 | |
| 86800 | <1% | 12 | $127.16 | |
| 94727 | <1% | 13 | $127.00 | |
| 95117 | <1% | 332 | $126.00 | |
| 0083A | <1% | 65 | $120.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 53 | $93.88 |
| 87338 | <1% | 1,501 | $92.32 | |
| 49083 | <1% | 50 | $88.95 | |
| 57454 | <1% | 12 | $77.53 | |
| 87799 | <1% | 125 | $73.92 | |
| 99307 | <1% | 50 | $68.36 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 38 | $64.00 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 17 | $60.49 |
| 82951 | <1% | 38 | $60.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 579 | $52.81 |
| 90658 | <1% | 50 | $35.76 | |
| 90685 | <1% | 86 | $25.66 | |
| J3490 | Unclassified drugs | <1% | 68 | $24.00 |
| 82952 | <1% | 38 | $20.00 | |
| 88108 | <1% | 31 | $17.91 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,051 | $16.99 |
| 96127 | <1% | 849 | $14.28 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 16 | $14.12 |
| 84311 | <1% | 12 | $12.84 | |
| 88720 | <1% | 108 | $12.78 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 100 | $11.60 |
| 83516 | <1% | 17 | $8.51 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 12 | $4.80 |
| 87088 | <1% | 815 | $4.51 | |
| 85014 | <1% | 228 | $1.93 | |
| 85018 | <1% | 196 | $1.86 | |
| G9920 | Screening performed and negative | <1% | 22,737 | $0.89 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 95 | $0.27 |
| 3044F | <1% | 719 | $0.02 | |
| 99024 | <1% | 2,014 | $0.01 | |
| 1036F | 0% | 46,188 | $0.00 | |
| 82043 | 0% | 984 | $0.00 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 47 | $0.00 |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 0% | 75 | $0.00 |
| 87070 | 0% | 131 | $0.00 | |
| 80197 | 0% | 22 | $0.00 | |
| 86803 | 0% | 160 | $0.00 | |
| 83735 | 0% | 185 | $0.00 | |
| 84153 | 0% | 252 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 190 | $0.00 |
| 86780 | 0% | 155 | $0.00 | |
| 82607 | 0% | 334 | $0.00 | |
| 87081 | 0% | 143 | $0.00 | |
| 92526 | 0% | 65 | $0.00 | |
| 87340 | 0% | 160 | $0.00 | |
| 83993 | 0% | 39 | $0.00 | |
| 94660 | 0% | 45 | $0.00 | |
| 90688 | 0% | 38 | $0.00 | |
| 86140 | 0% | 106 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 369 | $0.00 |
| 93016 | 0% | 41 | $0.00 | |
| 83550 | 0% | 338 | $0.00 | |
| 82728 | 0% | 334 | $0.00 | |
| 92227 | 0% | 459 | $0.00 | |
| 99349 | 0% | 76 | $0.00 | |
| 96150 | 0% | 27 | $0.00 | |
| 90378 | 0% | 12 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 25 | $0.00 |
| 82746 | 0% | 135 | $0.00 | |
| 84132 | 0% | 314 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 28 | $0.00 |
| 91318 | 0% | 13 | $0.00 | |
| 64615 | 0% | 12 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 1,257 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 243 | $0.00 |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 73 | $0.00 |
| 84134 | 0% | 12 | $0.00 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 0% | 12 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 183 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 28 | $0.00 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 168 | $0.00 |
| 31231 | 0% | 25 | $0.00 | |
| 93288 | 0% | 12 | $0.00 | |
| 82784 | 0% | 41 | $0.00 | |
| 58301 | 0% | 16 | $0.00 | |
| 81001 | 0% | 15 | $0.00 | |
| 83520 | 0% | 40 | $0.00 | |
| 93018 | 0% | 16 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 13 | $0.00 |
| D1206 | Topical application of fluoride varnish | 0% | 13 | $0.00 |
| 36591 | 0% | 39 | $0.00 | |
| 90661 | 0% | 2,486 | $0.00 | |
| 88262 | 0% | 12 | $0.00 | |
| 80061 | Lipid panel | 0% | 1,450 | $0.00 |
| 96153 | 0% | 838 | $0.00 | |
| 83970 | 0% | 149 | $0.00 | |
| 87186 | 0% | 235 | $0.00 | |
| 82274 | 0% | 570 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 242 | $0.00 |
| 84439 | 0% | 434 | $0.00 | |
| 3046F | 0% | 35 | $0.00 | |
| 86003 | 0% | 26 | $0.00 | |
| 29705 | 0% | 117 | $0.00 | |
| 83721 | 0% | 209 | $0.00 | |
| 84295 | 0% | 105 | $0.00 | |
| 82465 | 0% | 71 | $0.00 | |
| 83540 | 0% | 348 | $0.00 | |
| 90836 | 0% | 257 | $0.00 | |
| 85247 | 0% | 49 | $0.00 | |
| 84550 | 0% | 76 | $0.00 | |
| 83718 | 0% | 60 | $0.00 | |
| 84403 | 0% | 54 | $0.00 | |
| 54150 | 0% | 17 | $0.00 | |
| 93015 | 0% | 21 | $0.00 | |
| 83655 | 0% | 16 | $0.00 | |
| 11719 | 0% | 12 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 24 | $0.00 |
| 92582 | 0% | 12 | $0.00 | |
| 86645 | 0% | 29 | $0.00 | |
| 86334 | 0% | 33 | $0.00 | |
| 99218 | 0% | 28 | $0.00 | |
| 93017 | 0% | 41 | $0.00 | |
| 94726 | 0% | 19 | $0.00 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 13 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 16 | $0.00 |
| 81241 | 0% | 13 | $0.00 | |
| 86038 | 0% | 14 | $0.00 | |
| 86431 | 0% | 13 | $0.00 | |
| 88230 | 0% | 12 | $0.00 | |
| 82570 | 0% | 12 | $0.00 | |
| 11720 | 0% | 29 | $0.00 | |
| 94729 | 0% | 19 | $0.00 | |
| 84165 | 0% | 43 | $0.00 | |
| 71250 | 0% | 13 | $0.00 | |
| 90756 | 0% | 29 | $0.00 | |
| 17110 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.